Search/GRANT

The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)

HHS-NIH11GRANTFEDERALEquity-Free
Apply Now
ShareXinf
Amount
Not specified
Deadline
June 30, 2026
Bootstrap Score
3/10
Complexity
9/10

Track This Opportunity

Create an account to track opportunities.

About This Opportunity

This grant provides funding for academic organizations to lead clinical trials within the Experimental Therapeutics Clinical Trials Network (ETCTN). It's designed for institutions capable of conducting complex clinical trials, specifically requiring a UM1 Clinical Trial, to advance experimental therapeutics.

Eligibility Requirements

Required
Must be an academic organization capable of leading clinical trials.INDUSTRY
Required
Must be able to conduct UM1 Clinical Trials.INDUSTRY

Application Guide

Process
WRITTEN PROPOSAL
Difficulty
9/10
Selection Criteria

Selection will likely be based on the academic organization's demonstrated capability to lead experimental therapeutics clinical trials, experience with UM1 clinical trials, scientific merit of the proposed research, and institutional infrastructure.

Tips for Applicants

Focus on demonstrating extensive experience in clinical trial leadership and a robust infrastructure for experimental therapeutics. Clearly outline your institution's capacity to manage and execute UM1 clinical trials, highlighting past successes and relevant expertise.

Geographic Coverage

NATIONAL

Links & Resources

Source & freshness

Last verified: 6/16/2026

Primary source: Official source page

Refresh cadence: Listings are refreshed weekly.

Reminder: Confirm eligibility and deadlines before applying.

View all opportunities from HHS-NIH11